Business Context and Reporting Period
This Form 8-K reports on the Annual Meeting of Stockholders held by Finance of America Companies Inc. on June 8, 2023. The filing details the voting results for three proposals submitted to security holders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document focuses exclusively on corporate governance and voting outcomes rather than financial performance.
Material Changes and Voting Results
As of the record date (April 19, 2023), the total voting power was 233,191,413 votes. Shareholders representing 84.11% of the voting power were present or represented by proxy. All three proposals were approved:
- Proposal 1 (Election of Directors): Five nominees were elected to the Board for a term expiring at the 2024 annual meeting. Votes withheld ranged from approximately 278,000 to 9.5 million depending on the nominee.
- Proposal 2 (Say-on-Pay): Stockholders approved the advisory vote on Named Executive Officer compensation with 183,447,703 votes for and 350,150 votes against.
- Proposal 3 (Auditor Ratification): Stockholders ratified the appointment of BDO USA, LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2023, with 192,329,495 votes for and 3,632,714 votes against.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the reporting of the meeting's procedural outcomes.
Investor Verification Checklist
- Verify the specific terms of the newly elected directors' service until the 2024 annual meeting.
- Confirm the engagement letter and scope of work with the newly ratified auditor, BDO USA, LLP.
- Review the definitive proxy statement dated April 26, 2023, for detailed biographies of directors and executive compensation specifics.
- Note the significant number of broker non-votes (11,653,946) recorded for all proposals.